drugset / Trial / NCT04224519

Consistency Study for Three Commercial Lots of Inactivated Poliomyelitis Vaccine Made From Sabin Strain

NCT04224519 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

A randomized and blind clinical consistency study for three commercial batches of Inactivated Poliomyelitis Vaccine Made From Sabin Strain (sIPV) for immunogenicity and safety evaluation.

Timeline

Start
2018-04-15
Primary completion
2019-02-25
Completion
2019-10-12

Outcome

Met primary endpoint

paper In conclusion, sIPV exhibits good lot-to-lot consistency and safety in large-scale populations PMID 33487470 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Inactivated Poliomyelitis Vaccine Made From Sabin Strain Vaccine 30 unknown —
Subject Inactivated Poliomyelitis Vaccine Made From Sabin Strain Vaccine 32 unknown —
Subject Inactivated Poliomyelitis Vaccine Made From Sabin Strain Vaccine 45 unknown —

Indications